ATE138925T1 - Erythromycinderivate, herstellung und verwendung davon - Google Patents
Erythromycinderivate, herstellung und verwendung davonInfo
- Publication number
- ATE138925T1 ATE138925T1 AT93104504T AT93104504T ATE138925T1 AT E138925 T1 ATE138925 T1 AT E138925T1 AT 93104504 T AT93104504 T AT 93104504T AT 93104504 T AT93104504 T AT 93104504T AT E138925 T1 ATE138925 T1 AT E138925T1
- Authority
- AT
- Austria
- Prior art keywords
- hemiacetal
- salt
- erythromycin derivative
- positions
- hydroxyl group
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 230000007661 gastrointestinal function Effects 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 102000004316 Oxidoreductases Human genes 0.000 abstract 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6424392 | 1992-03-19 | ||
| JP15246792 | 1992-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE138925T1 true ATE138925T1 (de) | 1996-06-15 |
Family
ID=26405362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93104504T ATE138925T1 (de) | 1992-03-19 | 1993-03-19 | Erythromycinderivate, herstellung und verwendung davon |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5470961A (de) |
| EP (1) | EP0561413B1 (de) |
| AT (1) | ATE138925T1 (de) |
| CA (1) | CA2092045C (de) |
| DE (1) | DE69302938T2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2092045C (en) * | 1992-03-19 | 2004-08-10 | Setsuo Harada | Erythromycin derivatives, preparation and use thereof |
| US6077943A (en) * | 1996-03-01 | 2000-06-20 | Takeda Chemical Industries, Ltd. | Method of producing erythromycin derivative |
| DE19805822B4 (de) * | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| CA2399198A1 (en) | 2000-02-18 | 2001-08-23 | Christopher Carreras | Motilide compounds |
| JP2004530108A (ja) | 2001-02-15 | 2004-09-30 | コーサン バイオサイエンシーズ, インコーポレイテッド | 治療効力を評価するための方法 |
| US7521420B2 (en) | 2003-06-18 | 2009-04-21 | Tranzyme Pharma, Inc. | Macrocyclic antagonists of the motilin receptor |
| US20050113319A1 (en) * | 2003-08-26 | 2005-05-26 | Christopher Carreras | 11-Deoxy-6,9-ether erythromycin compounds |
| US7407941B2 (en) * | 2003-08-26 | 2008-08-05 | Pfizer, Inc. | N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
| US7211568B2 (en) * | 2003-12-18 | 2007-05-01 | Kosan Biosciences Incorporated | 9-Desoxoerythromycin compounds as prokinetic agents |
| US7582611B2 (en) * | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
| JP2009518396A (ja) * | 2005-12-08 | 2009-05-07 | ファイザー・インク | エリスロマイシン化合物の3’−ジメチルアミノ基を脱メチルする方法 |
| EP2054429B1 (de) | 2006-09-11 | 2013-11-06 | Tranzyme Pharma, Inc. | Makrozyklische motilinrezeptor antagonisten zur behandlung von gastro-intestinaler störungen |
| KR101120483B1 (ko) * | 2006-12-05 | 2012-02-29 | 브리스톨-마이어즈 스퀴브 컴페니 | 모틸라이드 다형체 |
| US20080287371A1 (en) * | 2007-05-17 | 2008-11-20 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex |
| WO2022146980A1 (en) * | 2020-12-28 | 2022-07-07 | Georgia Tech Research Corporation | Compositions and methods for inhibiting fibrosis, inflammation and cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2926959A1 (de) * | 1979-07-04 | 1981-01-22 | Hoechst Ag | Vorrichtung zur fluessig-fluessig- extraktion |
| US5008249A (en) * | 1985-08-31 | 1991-04-16 | Kitasato Kenkyusho | Therapeutic method of stimulating digestive tract contractile motion in mammals |
| EP0215355B1 (de) * | 1985-08-31 | 1994-04-06 | Kitasato Kenkyusho | Erythromycinderivat und Verfahren zu dessen Herstellung |
| US4672056A (en) * | 1985-11-12 | 1987-06-09 | Abbott Laboratories | Erythromycin A derivatives and method of use |
| JPH0633312B2 (ja) * | 1986-05-02 | 1994-05-02 | 大正製薬株式会社 | 14−ハイドロキシエリスロマイシン誘導体およびその製造方法 |
| US5106961A (en) * | 1987-05-26 | 1992-04-21 | Eli Lilly And Company | Erythromycin ring-contracted derivatives |
| US4920102A (en) * | 1988-04-18 | 1990-04-24 | Eli Lilly And Company | Method for treating gastrointestinal disorders |
| CA2092045C (en) * | 1992-03-19 | 2004-08-10 | Setsuo Harada | Erythromycin derivatives, preparation and use thereof |
-
1993
- 1993-03-19 CA CA002092045A patent/CA2092045C/en not_active Expired - Fee Related
- 1993-03-19 AT AT93104504T patent/ATE138925T1/de not_active IP Right Cessation
- 1993-03-19 DE DE69302938T patent/DE69302938T2/de not_active Expired - Fee Related
- 1993-03-19 EP EP93104504A patent/EP0561413B1/de not_active Expired - Lifetime
- 1993-03-19 US US08/033,777 patent/US5470961A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/475,557 patent/US5854407A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0561413B1 (de) | 1996-06-05 |
| DE69302938D1 (de) | 1996-07-11 |
| DE69302938T2 (de) | 1996-10-17 |
| EP0561413A1 (de) | 1993-09-22 |
| CA2092045A1 (en) | 1993-09-20 |
| CA2092045C (en) | 2004-08-10 |
| US5854407A (en) | 1998-12-29 |
| US5470961A (en) | 1995-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE138925T1 (de) | Erythromycinderivate, herstellung und verwendung davon | |
| TW289020B (de) | ||
| ATE60334T1 (de) | Chinazolinonderivat und verfahren zu seiner herstellung. | |
| DE69615802D1 (de) | Heterocyclische substituierte Benzofuran-Harnstoffe | |
| ATE118764T1 (de) | Persäure-clathrate, ihre herstellung und ihre verwendungen. | |
| HU9201288D0 (en) | Kinoxalyne derivatives, process for their production and medical preparations containing them | |
| FI101376B1 (fi) | Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi | |
| SE9003476D0 (sv) | Novel isoindole derivatives and salts thereof, process for producing the same and antitumor agent comprising the same | |
| DE3776391D1 (de) | Fluessige zubereitungen von 1,2-benzisothiazolin-3-on, ihre herstellung und verwendung. | |
| HUT58049A (en) | Process for producing guanidine derivatives and insecticidal compositions comprising same | |
| ES8609271A1 (es) | Procedimiento para preparar derivados de carbamoilimidazol fungicidas | |
| DE69124844D1 (de) | Radicicol-Derivate, ihre Herstellung und ihre Antitumorwirkung | |
| DE58905079D1 (de) | Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung. | |
| AU600054B2 (en) | 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m- phenylene pgi2 derivatives | |
| DE59206398D1 (de) | Verfahren zur Herstellung von 1-Carbamoyl-pyrazolen | |
| ATE90685T1 (de) | Disaccharidderivate. | |
| EP0118564A4 (de) | 4-amino-tetrahydro-2-naphthoesäureabkömmlinge. | |
| ATE132500T1 (de) | 24r-scymnol, herstellung und verwendung | |
| PH23992A (en) | Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same | |
| PT87563A (pt) | Process for the preparation of vinylcephalosporins useful as medicaments | |
| DE58906618D1 (de) | Strobilurinderivate, ihre Herstellung und Verwendung. | |
| ATE133177T1 (de) | 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung | |
| DE69511449D1 (de) | Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung | |
| ATE157081T1 (de) | Beta-phenylisoserin-(2r,3s), ihre salze, herstellung und verwendung | |
| DE69107902D1 (de) | Carbaminsäurederivate, ihre Herstellung und Verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |